RGNX - REGENXBIO Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending2018-12-312017-12-312016-12-312015-12-31
Net Income99,937-73,169-62,967-22,811
Operating Activities, Cash Flows Provided By or Used In
Depreciation3,9822,68654480
Adjustments To Net Income8,50311,5948,6363,256
Changes In Accounts Receivables-16,8035611,073-265
Changes In Liabilities3,7152,62159564
Changes In Inventories----
Changes In Other Operating Activities5,314-2,2854,097-3,339
Total Cash Flow From Operating Activities104,648-57,992-48,558-22,515
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-13,278-7,160-8,149-522
Investments-266,0802,37027,537-163,278
Other Cash flows from Investing Activities---225-225
Total Cash Flows From Investing Activities-279,358-4,79019,388-163,800
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings----
Other Cash Flows from Financing Activities-619-445-60-2,502
Total Cash Flows From Financing Activities204,44384,598119239,310
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents29,73321,816-29,05152,995